Completed NA INTERVENTIONAL 2-arm NCT00857077

Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana

Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation

Sponsor: Department for International Development, United Kingdom

Interventions Placebo Sulfadoxine-pyrimethamine

Updated 6 times since 2017 Last updated: Jan 25, 2017 Started: Sep 30, 2000 Completion: Jun 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anaemia and Malaria, this trial is completed. The trial is conducted by Department for International Development, United Kingdom and has accumulated 6 data snapshots since 2000. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Department for International Development, United Kingdom
INDEPTH Network
Kintampo Health Research Centre, Ghana
London School of Hygiene and Tropical Medicine
Navrongo Health Research Centre, Navrongo, Ghana.

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Navrongo, Ghana